Kailera Therapeutics Inc.
KLRA | NASDAQ
$12.46
-$0.40 (-3.11%)
Nov 2, 2026, 10:46 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
Net Income | -111.31M | -78.87M |
Depreciation & Amortization | 101K | 101K |
Stock-Based Compensation | 8.34M | 3.94M |
Other Working Capital | 14.38M | 7.96M |
Other Non-Cash Items | -1.39M | -951K |
Deferred Income Tax | n/a | n/a |
Change in Working Capital | 26.72M | 7.47M |
Operating Cash Flow | -77.53M | -68.31M |
Capital Expenditures | n/a | n/a |
Cash Acquisitions | n/a | n/a |
Purchase of Investments | -689.81M | -48.45M |
Sales Maturities Of Investments | 118.79M | 71.3M |
Other Investing Acitivies | n/a | n/a |
Investing Cash Flow | -571.02M | 22.85M |
Debt Repayment | n/a | n/a |
Common Stock Repurchased | n/a | n/a |
Dividend Paid | n/a | n/a |
Other Financial Acitivies | -1.84M | -3.04M |
Financial Cash Flow | 667.03M | -2.98M |
Net Cash Flow | 18.48M | -48.44M |
Free Cash Flow | -77.53M | -68.31M |
Adj. Free Cash Flow | -85.87M | -72.25M |
Maintenance CapEx | n/a | n/a |
Growth CapEx | n/a | n/a |
Owner Earnings | -77.53M | -68.31M |
Add to Watchlist
Select watchlists to add or remove KLRA